An integrated technology for quantitative wide mutational scanning of human antibody Fab libraries
Brian M. PeterseniD, Monica B. KirbyiD, Karson M ChrispensiD, Olivia M. Irvin, Isabell K. Strawn, Cyrus M. HaasiD, Alexis M. WalkeriD, Zachary T. BaumeriD, Sophia A. Ulmer, Edgardo Ayala, Emily R. Rhodes, Jenna J. GuthmilleriD, Paul J. SteineriD, Timothy A. WhiteheadiD
Abstract
Antibodies are engineerable quantities in medicine. Learning antibody molecular recognition would enable the in silico design of high affinity binders against nearly any proteinaceous surface. Yet, publicly available experiment antibody sequence-binding datasets may not contain the mutagenic, antigenic, or antibody sequence diversity necessary for deep learning approaches to capture molecular recognition. In part, this is because limited experimental platforms exist for assessing quantitative and simultaneous sequence-function relationships for multiple antibodies. Here we present MAGMA-seq, an integrated technology that combines multiple antigens and multiple antibodies and determines quantitative biophysical parameters using deep sequencing. We demonstrate MAGMA-seq on two pooled libraries comprising mutants of ten different human antibodies spanning light chain gene usage, CDR H3 length, and antigenic targets. We demonstrate the comprehensive mapping of potential antibody development pathways, sequence-binding relationships for multiple antibodies simultaneously, and identification of paratope sequence determinants for binding recognition for broadly neutralizing antibodies (bnAbs). MAGMA-seq enables rapid and scalable antibody engineering of multiple lead candidates because it can measure binding for mutants of many given parental antibodies in a single experiment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 26
- FWCI
- 3.89
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep learning enables therapeutic antibody optimization in mammalian cells by deciphering high-dimensional protein sequence space
Derek M. Mason, Simon Friedensohn, … Sai T. Reddy·bioRxiv·Jun 2, 2019
- AlphaBind, a Domain-Specific Model to Predict and Optimize Antibody-Antigen Binding Affinity
Aditya A. Agarwal, James Harrang, … Ryan Emerson·mAbsPeer-reviewed·Jul 22, 2025
- Antibody affinity engineering using antibody repertoire data and machine learning
Lena Erlach, Simon Friedensohn, … Sai T. Reddy·bioRxiv·Jan 10, 2025
- Antibody optimization enabled by artificial intelligence predictions of binding affinity and naturalness
Sharrol T. Bachas, Goran Rakocevic, … Roberto Spreafico·bioRxiv·Aug 16, 2022
- In silico proof of principle of machine learning-based antibody design at unconstrained scale
R. Akbar, P. A. Robert, … V. Greiff·bioRxiv·Jul 8, 2021
- High-Throughput Machine Learning-Aided Antibody Discovery for Cell Surface Antigens
Deepash Kothiwal, Aaron W. Kollasch, … Rob Meijers·Cell SystemsPeer-reviewed·Jun 23, 2026